Status:
TERMINATED
EMS Prehospital Blood Culture Collection and Antibiotic Administration: A Two-Phase Pilot Project to Reduce Mortality in Patients With Severe Sepsis and Septic Shock
Lead Sponsor:
HealthPartners Institute
Conditions:
Sepsis
Sepsis, Severe
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
This study is designed to improve the outcomes for patients suffering from severe sepsis and septic shock (SS/SS) by decreasing the time from first medical contact to antibiotic administration. This i...
Detailed Description
This study is designed to improve the outcomes for patients suffering from severe sepsis and septic shock (SS/SS) by decreasing the time from first medical contact to antibiotic administration. This i...
Eligibility Criteria
Inclusion
- Phase 1 (blood culture contamination rate quantification phase)
- Hemodynamically stable patients ≥18 years old being transported by Lakeview EMS to Lakeview Hospital who will have an intravenous access established as part of their routine prehospital care are eligible for this study.
- English speaker
- Phase 2 (blood cultures + antibiotics prehospital)
- a. Patients with fever \>38oC + ≥2 qSOFA who are being transported to Lakeview Hospital that originate as a 911 call
Exclusion
- Phase 1:
- Patients age \<18 years
- Hemodynamic instability
- Prisoners
- Phase 2:
- Documented allergy to Penicillin or inability to determine patient's medication allergies
- Prisoners
- Pregnant patients
- Patients being transferred from one hospital to another
- Non-English speakers
Key Trial Info
Start Date :
September 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 8 2021
Estimated Enrollment :
215 Patients enrolled
Trial Details
Trial ID
NCT04134624
Start Date
September 11 2019
End Date
July 8 2021
Last Update
September 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lakeview Hospital
Stillwater, Minnesota, United States, 55082